Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (41-50 of 351) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Better performance of CARs deprived of the PD-1 brakeAizea Morales-Kastresana, Sara Labiano, José I Quetglas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2018
For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive ImmunityIvan Marquez-Rodas, María Angela Aznar, Antonio Calles, et al.
The Surgical Clinics of North America|April 6, 2004
Biologic therapy of liver tumorsJesus Prieto, Cheng Qian, Bruno Sangro, et al.
Journal of Hepatology|December 16, 2003
MAGE antigens: therapeutic targets in hepatocellular carcinoma?Pablo Sarobe, Esperanza Feijoó, Carlos Alfaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2020
Interleukin-12 Message in a BottleAssunta Cirella, Pedro Berraondo, Claudia Augusta Di Trani, et al.
Cancer Discovery|July 4, 2018
Epistatic Oncogenic Interactions Determine Cancer Susceptibility to ImmunotherapyIñaki Etxeberria, Alvaro Teijeira, Luis M Montuenga, et al.
Trends in Immunology|June 24, 2026
Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinationsGabriel Gomis, Pedro Berraondo, Claudia Herrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Revisiting Intracavitary Immunotherapy of CancerFernando Aranda, Iñaki Eguren-Santamaria, Ángela Bella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Engineering and improving anti-CTLA-4 checkpoint inhibitorsFelipe Galvez-Cancino, Eileen E Parkes, David R Withers, et al.
Nature Cancer|June 28, 2022
Charting roadmaps towards novel and safe synergistic immunotherapy combinationsMiguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, et al.
Pageof 36

Showing results (41-50 of 351) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Better performance of CARs deprived of the PD-1 brakeAizea Morales-Kastresana, Sara Labiano, José I Quetglas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2018
For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive ImmunityIvan Marquez-Rodas, María Angela Aznar, Antonio Calles, et al.
The Surgical Clinics of North America|April 6, 2004
Biologic therapy of liver tumorsJesus Prieto, Cheng Qian, Bruno Sangro, et al.
Journal of Hepatology|December 16, 2003
MAGE antigens: therapeutic targets in hepatocellular carcinoma?Pablo Sarobe, Esperanza Feijoó, Carlos Alfaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2020
Interleukin-12 Message in a BottleAssunta Cirella, Pedro Berraondo, Claudia Augusta Di Trani, et al.
Cancer Discovery|July 4, 2018
Epistatic Oncogenic Interactions Determine Cancer Susceptibility to ImmunotherapyIñaki Etxeberria, Alvaro Teijeira, Luis M Montuenga, et al.
Trends in Immunology|June 24, 2026
Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinationsGabriel Gomis, Pedro Berraondo, Claudia Herrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Revisiting Intracavitary Immunotherapy of CancerFernando Aranda, Iñaki Eguren-Santamaria, Ángela Bella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2026
Engineering and improving anti-CTLA-4 checkpoint inhibitorsFelipe Galvez-Cancino, Eileen E Parkes, David R Withers, et al.
Nature Cancer|June 28, 2022
Charting roadmaps towards novel and safe synergistic immunotherapy combinationsMiguel F Sanmamed, Pedro Berraondo, Maria E Rodriguez-Ruiz, et al.
Pageof 36